BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31904348)

  • 1. Kallikrein-related peptidases protein expression in lymphoid tissues suggests potential implications in immune response.
    Filippou PS; Ren AH; Soosaipillai A; Safar R; Prassas I; Diamandis EP; Conner JR
    Clin Biochem; 2020 Mar; 77():41-47. PubMed ID: 31904348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Expression of Kallikreins in Breast Cancer Cell Lines.
    Watrowski R; Castillo-Tong DC; Obermayr E; Zeillinger R
    Anticancer Res; 2020 May; 40(5):2487-2495. PubMed ID: 32366393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of 15 human kallikreins in tissues and biological fluids.
    Shaw JL; Diamandis EP
    Clin Chem; 2007 Aug; 53(8):1423-32. PubMed ID: 17573418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human kallikrein-related peptidase 12: antibody generation and immunohistochemical localization in prostatic tissues.
    Memari N; Diamandis EP; Earle T; Campbell A; Van Dekken H; Van der Kwast TH
    Prostate; 2007 Sep; 67(13):1465-74. PubMed ID: 17654496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The canine kallikrein-related peptidases 9 and 10: structural characterization and expression in mammary cancer.
    Angelopoulou K; Karagiannis GS
    Mamm Genome; 2009; 20(11-12):758-67. PubMed ID: 19953256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kallikreins as microRNA targets: an in silico and experimental-based analysis.
    Chow TF; Crow M; Earle T; El-Said H; Diamandis EP; Yousef GM
    Biol Chem; 2008 Jun; 389(6):731-8. PubMed ID: 18627289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and bioregulation of the kallikrein-related peptidases family in the human neutrophil.
    Lizama AJ; Andrade Y; Colivoro P; Sarmiento J; Matus CE; Gonzalez CB; Bhoola KD; Ehrenfeld P; Figueroa CD
    Innate Immun; 2015 Aug; 21(6):575-86. PubMed ID: 25563717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A completed KLK activome profile: investigation of activation profiles of KLK9, 10, and 15.
    Yoon H; Blaber SI; Debela M; Goettig P; Scarisbrick IA; Blaber M
    Biol Chem; 2009 Apr; 390(4):373-7. PubMed ID: 19090718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis.
    Yoon H; Blaber SI; Evans DM; Trim J; Juliano MA; Scarisbrick IA; Blaber M
    Protein Sci; 2008 Nov; 17(11):1998-2007. PubMed ID: 18697857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients.
    Komatsu N; Saijoh K; Kuk C; Liu AC; Khan S; Shirasaki F; Takehara K; Diamandis EP
    Exp Dermatol; 2007 Jun; 16(6):513-9. PubMed ID: 17518992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profile of human tissue kallikrein 15 provides preliminary insights into its roles in the prostate and testis.
    Filippou PS; Ren AH; Soosaipillai A; Papaioannou MD; Korbakis D; Safar R; Diamandis EP; Conner JR
    Clin Biochem; 2018 Sep; 59():78-85. PubMed ID: 29958881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The GNA13-RhoA signaling axis suppresses expression of tumor protective Kallikreins.
    Teo CR; Casey PJ; Rasheed SA
    Cell Signal; 2016 Oct; 28(10):1479-88. PubMed ID: 27424208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.
    Avgeris M; Scorilas A
    Expert Opin Ther Targets; 2016 Jul; 20(7):801-18. PubMed ID: 26941073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kallikrein-related peptidases in lung diseases.
    Lenga Ma Bonda W; Iochmann S; Magnen M; Courty Y; Reverdiau P
    Biol Chem; 2018 Sep; 399(9):959-971. PubMed ID: 29604204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of tissue kallikrein and kallikrein-related peptidases in breast cancer.
    Figueroa CD; Molina L; Bhoola KD; Ehrenfeld P
    Biol Chem; 2018 Sep; 399(9):937-957. PubMed ID: 29885274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallikrein-related peptidases in cancers of gastrointestinal tract: an inside view of their role and clinical significance.
    Linardoutsos D; Gazouli M; Machairas A; Bramis I; Zografos GC
    J BUON; 2014; 19(1):53-9. PubMed ID: 24659643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterization and expression of five novel canine kallikrein-related peptidases in mammary cancer.
    Angelopoulou K; Karagiannis GS
    Mamm Genome; 2010 Oct; 21(9-10):516-24. PubMed ID: 20853168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy.
    Komatsu N; Saijoh K; Kuk C; Shirasaki F; Takehara K; Diamandis EP
    Br J Dermatol; 2007 May; 156(5):875-83. PubMed ID: 17459012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation profiles and regulatory cascades of the human kallikrein-related peptidases.
    Yoon H; Laxmikanthan G; Lee J; Blaber SI; Rodriguez A; Kogot JM; Scarisbrick IA; Blaber M
    J Biol Chem; 2007 Nov; 282(44):31852-64. PubMed ID: 17823117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal and tissue-specific expression of kallikrein (Klk) genes and identification of a novel Klk messenger ribonucleic acid transcript during early development in the mouse.
    Chan CS; Harvey MB; Clements JA
    Biol Reprod; 1999 Sep; 61(3):621-8. PubMed ID: 10456837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.